CASR and hypoparathyroidism: Cinacalcet is hypothesized to mitigate the effects of paraneoplastic FGF23 in TIO by activating parathyroid gland calcium-sensing receptors, inducing hypoparathyroidism, resulting in increased renal retention of phosphate [6].